Background Delirium is a prevalent clinical presentation in advanced illness. The hyperactive phase can cause severe symptoms at the end of life. There is no published study of the pharmacological ...

Correspondence to Josie Dixon, Personal Social Services Research Unit (PSSRU), London School of Economics and Political Science, Houghton Street, London WC2A 2AE, UK; j.e.dixon{at}lse.ac.uk Objectives ...

5 Centre for Aging Research and Education, Duke-NUS Medical School, Singapore 6 Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore Background Family caregivers of patients with ...

Objectives Patients with indicators for palliative care, such as those with advanced life-limiting conditions, are at risk of futile cardiopulmonary resuscitation (CPR) if they suffer out-of-hospital ...

Correspondence to Dr Stacey Panozzo, Palliative Nexus, St Vincent's Hospital Melbourne, Melbourne, VIC 3065, Australia; stacey.panozzo{at}svha.org.au Background While clinical wisdom has long provided ...

Correspondence to Professor Irene J Higginson, King's College London, Cicely Saunders Institute, Department of Palliative Care, Policy and Rehabilitation, Bessemer Road, Denmark Hill, London SE5 9PJ, ...

Background Communication about the end of life is especially important in the family context, as patients and their families are considered as the care unit in palliative care. Open end-of-life ...

Correspondence to Dr Mette Asbjoern Neergaard, Palliative Care Unit, Department of Oncology, Aarhus University Hospital, Aarhus 8200, Denmark; mettneer{at}rm.dk Advance care planning (ACP) can be a ...

Objectives Palliative care phases (stable, unstable, deteriorating, terminal and bereavement) are useful in describing the palliative care situation of patients/relatives and their care needs as well ...

Objectives The study evaluates the fifth cohort of the palliative care cancer treatment centres (CTC) educational programme in India with the aim of refining the course on the basis of participant ...

Objective Improper use of human albumin (HA) is now common in clinical settings. This study aims to explore the feasibility of the plan-do-check-act (PDCA) cycle in promoting the rational use of HA.